112 related articles for article (PubMed ID: 2264585)
21. Prognostic value of initial mononucleated cell percentages in patients with epidermoid carcinoma of the head and neck.
Elias EG; Leuchten JM; Buda BS; Brown SD
Am J Surg; 1986 Nov; 152(5):487-90. PubMed ID: 3777326
[TBL] [Abstract][Full Text] [Related]
22. Zinc and copper levels in whole blood and plasma from patients with squamous cell carcinomas of head and neck.
Abdulla M; Biörklund A; Mathur A; Wallenius K
J Surg Oncol; 1979; 12(2):107-13. PubMed ID: 491677
[TBL] [Abstract][Full Text] [Related]
23. Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in malignancy.
Nabholtz JM; Rossignol A; Farnier M; Gambert P; Tremeaux JC; Friedman S; Guerrin J
Acta Oncol; 1988; 27(5):479-82. PubMed ID: 3203006
[TBL] [Abstract][Full Text] [Related]
24. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
[TBL] [Abstract][Full Text] [Related]
25. Phase II evaluation of diaziquone in recurrent head and neck cancer.
Kish JA; Ensley J; Al-Sarraf M
Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616
[No Abstract] [Full Text] [Related]
26. [Serum levels of tissue polypeptide antigen in patients with the head and neck cancer according to presence of metastases in lymph nodes].
Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M; Chmurzyńska A
Otolaryngol Pol; 2000; 54 Suppl 31():206-8. PubMed ID: 10974886
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma.
Riedel F; Götte K; Schwalb J; Hörmann K
Anticancer Res; 2000; 20(5A):3045-9. PubMed ID: 11062721
[TBL] [Abstract][Full Text] [Related]
28. Crystallization test for the detection of head and neck cancer.
Gulati SP; Sachdeva OP; Sachdeva A; Adlakha RP; Kakkar V
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):283-6. PubMed ID: 7970613
[TBL] [Abstract][Full Text] [Related]
29. [Prostatic tumors. Detection by proton nuclear magnetic resonance spectroscopy of plasma lipoproteins].
Nabholtz JM; Tremeaux JC; Rossignol A; Farnier M; Gambert P; Briet S; Guerrin J
J Urol (Paris); 1989; 95(4):209-12. PubMed ID: 2477463
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
[TBL] [Abstract][Full Text] [Related]
31. Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer.
Tartour E; Mosseri V; Jouffroy T; Deneux L; Jaulerry C; Brunin F; Fridman WH; Rodriguez J
Lancet; 2001 Apr; 357(9264):1263-4. PubMed ID: 11418153
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumour cell PD-L1 test for head and neck cancers.
Kulasinghe A; Kenny L; Punyadeera C
Oral Oncol; 2017 Dec; 75():6-7. PubMed ID: 29224824
[TBL] [Abstract][Full Text] [Related]
33. Nuclear magnetic resonance spectroscopy of plasma for the detection of head and neck cancer.
Dawson DE; Sekhar V; Pearson G; Vaickus L
Am J Otolaryngol; 1989; 10(4):244-9. PubMed ID: 2764236
[TBL] [Abstract][Full Text] [Related]
34. Serum concentrations of laminin gamma2 fragments in patients with head and neck squamous cell carcinoma.
Kuratomi Y; Sato S; Monji M; Shimazu R; Tanaka G; Yokogawa K; Inoue A; Inokuchi A; Katayama M
Head Neck; 2008 Aug; 30(8):1058-63. PubMed ID: 18446818
[TBL] [Abstract][Full Text] [Related]
35. [Alpha-fetoprotein--diagnostic utility in squamous cell carcinoma of the head and neck].
Adamiak G; Ligeziński A; Jurkiewicz D; Hermanowski M; Konieczna M
Pol Merkur Lekarski; 2001 Oct; 11(64):320-2. PubMed ID: 11770310
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
[TBL] [Abstract][Full Text] [Related]
37. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
38. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions.
Patel PS; Shah MH; Jha FP; Raval GN; Rawal RM; Patel MM; Patel JB; Patel DD
Indian J Cancer; 2004; 41(1):25-31. PubMed ID: 15105576
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma antigen in serum for monitoring of head and neck and uterine cervical squamous cell carcinomas after radiotherapy.
Shirato H; Ichimura W; Wakushima H; Nishioka T; Suzuki K
Acta Oncol; 1993; 32(6):663-6. PubMed ID: 8260185
[TBL] [Abstract][Full Text] [Related]
40. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck.
Rhee D; Wenig BM; Smith RV
Laryngoscope; 2002 Nov; 112(11):1970-4. PubMed ID: 12439164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
